Travere Therapeutics, Inc.

Travere Therapeutics, Inc.

TVTX
Travere Therapeutics, Inc.US flagNASDAQ Global Market
56.58
USD
+1.11
- -
5.26BMarket Cap

Travere Therapeutics, Inc. (TVTX) Stock Split History

Learn about Travere Therapeutics, Inc.'s most recent 1-for-9 basis stock split on November 02, 2012. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Travere Therapeutics, Inc.'s most recent stock split

Split Date: 2012-11-02
Split Ratio: 1:9
Price Before Split: N/A
Price After Split: N/A

Developer API

Get TVTX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/TVTX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 9.00 times fewer shares (a 1:9 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Travere Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2012-11-021:9YesN/AN/A
2009-07-021:100YesN/AN/A

About Travere Therapeutics, Inc.

Company overview and industry information

Travere Therapeutics, Inc. (TVTX) operates in the Biotechnology industry. The recent 1-for-9 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Travere Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.